Last CNY15.78 CNY
Change Today +0.12 / 0.77%
Volume 2.3M
002107 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

shandong wohua pharmaceuti-a (002107) Snapshot

Open
CNY15.66
Previous Close
CNY15.66
Day High
CNY15.98
Day Low
CNY15.50
52 Week High
08/20/14 - CNY15.98
52 Week Low
12/23/13 - CNY10.28
Market Cap
2.6B
Average Volume 10 Days
2.1M
EPS TTM
CNY0.08
Shares Outstanding
164.0M
EX-Date
08/21/14
P/E TM
197.5x
Dividend
CNY0.06
Dividend Yield
0.38%
Current Stock Chart for SHANDONG WOHUA PHARMACEUTI-A (002107)

Related News

No related news articles were found.

shandong wohua pharmaceuti-a (002107) Related Businessweek News

No Related Businessweek News Found

shandong wohua pharmaceuti-a (002107) Details

Shandong Wohua Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese traditional patent medicines primarily for the treatment of cardiovascular and cerebrovascular diseases in China. The company also provides products in the areas of respiratory, women and children's medication, urinary system, digestive system, and anti-rheumatic diseases. It offers tablets, hard capsules, granules, pills, powders, oral solutions, mixtures, alcoholature, soft extracts, syrup, dripping pills, extracorporeal diagnostic reagents, and others. The company’s primary products include Xinkeshu tablets and capsules for the treatment of coronary heart disease; Naoxueshu Oral Liquid, which promotes blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus; and Yuandu granules to treat influenza. Shandong Wohua Pharmaceutical Co., Ltd. is based in Weifang, China.

shandong wohua pharmaceuti-a (002107) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shandong wohua pharmaceuti-a (002107) Key Developments

Shandong Wohua Pharmaceutical Co., Ltd. Announces 2013 Final Cash Dividend Payable on August 21, 2014

Shandong Wohua Pharmaceutical Co., Ltd. announced 2013 final distribution plan to be implemented (A shares) as follows: cash dividend/10 shares (tax included) is CNY 0.60000000 payable on August 21, 2014, record date on August 20, 2014 and ex date on August 21, 2014.

Shandong Wohua Pharmaceutical Co., Ltd. to Report Q2, 2014 Results on Aug 02, 2014

Shandong Wohua Pharmaceutical Co., Ltd. announced that they will report Q2, 2014 results on Aug 02, 2014

Shandong Wohua Pharmaceutical Co., Ltd. Approves Cash Dividend for 2013; Announces Executive Appointments

Shandong Wohua Pharmaceutical Co., Ltd. at its Annual General Meeting of 2013, held on June 26, 2014, approved cash dividend per 10 shares (tax included) of CNY 0.60 for 2013. The company approved the appointment of Wang Jiong as non-independent director and Wang Guihua as independent director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002107:CH CNY15.78 CNY +0.12

002107 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002107.
View Industry Companies
 

Industry Analysis

002107

Industry Average

Valuation 002107 Industry Range
Price/Earnings 100.0x
Price/Sales 10.6x
Price/Book 4.3x
Price/Cash Flow 216.1x
TEV/Sales 8.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG WOHUA PHARMACEUTI-A, please visit www.wohua.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.